CBP-1018
CBP-1018 is a peptide-drug conjugate (PDC) designed for breast cancer research, featuring a ligand targeting FRα and TRPV6 linked to the cytotoxic payload MMAE. It is utilized in preclinical studies to investigate targeted drug delivery and efficacy in both in vitro and in vivo models of cancer.
Product Specifications
Field of Research
Pharmacology & Drug Discovery
Molecular Weight
2839.18
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7253574-01 48 Well
Canine Cdc42-interacting protein 4 (TRIP10) ELISA Kit
Sign In for Pricing
View Details